SUPERNUS PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2011 to Q1 2024.
  • Supernus Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Interest Expense for 2021 was $19.7M, a 1.34% increase from 2020.
  • Supernus Pharmaceuticals, Inc. annual Interest Expense for 2020 was $19.4M, a 6.75% increase from 2019.
  • Supernus Pharmaceuticals, Inc. annual Interest Expense for 2019 was $18.2M, a 31.6% increase from 2018.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 -$1.51M -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q3 2023 $0 -$1.72M -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $910K -$900K -49.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.51M -$437K -22.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q3 2022 $7.68M $1.72M -$4.2M -70.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $11.9M $1.81M -$3.66M -66.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $15.5M $1.94M -$4.16M -68.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $19.7M $2.21M +$430K +24.2% Oct 1, 2021 Dec 31, 2021 10-K 2022-04-13
Q3 2021 $19.3M $5.93M -$163K -2.68% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $19.4M $5.47M -$348K -5.99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $19.8M $6.1M +$342K +5.94% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $19.4M $1.78M Oct 1, 2020 Dec 31, 2020 10-K 2022-04-13
Q3 2020 $6.09M +$426K +7.52% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $5.82M +$426K +7.91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $5.76M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q3 2019 $5.66M +$1.29M +29.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $5.39M +$1.07M +24.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-17
Q4 2018 $13.8M $4.43M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-08
Q3 2018 $4.37M Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $4.32M +$4.27M +7355% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $717K +$627K +697% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q2 2017 $316K $58K -$138K -70.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $454K $90K -$89K -49.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $543K -$34K -$259K -115% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $802K $202K -$90K -30.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $892K $196K -$135K -40.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $1.03M $179K -$202K -53% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $1.23M $225K -$964K -81.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $2.19M $292K -$997K -77.3% Jul 1, 2015 Sep 30, 2015 10-Q 2017-01-20
Q2 2015 $3.19M $331K -$947K -74.1% Apr 1, 2015 Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 $4.14M $381K -$826K -68.4% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 $4.96M $1.19M -$919K -43.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $5.88M $1.29M -$1.58M -55.1% Jul 1, 2014 Sep 30, 2014 10-Q/A 2017-01-20
Q2 2014 $7.46M $1.28M -$866K -40.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $8.33M $1.21M +$480K +66% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $7.85M $2.11M +$1.3M +162% Oct 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
Q3 2013 $6.55M $2.87M +$1.99M +226% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $4.56M $2.14M +$1.22M +131% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $3.34M $727K -$235K -24.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $3.58M $804K +$296K +58.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $3.28M $880K +$381K +76.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $2.9M $929K +$430K +86.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $2.47M $962K +$602K +167% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $1.87M $508K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-21
Q3 2011 $499K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $499K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 $360K Jan 1, 2011 Mar 31, 2011 10-Q 2012-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.